公式財務諸表に基づく売上高、利益、キャッシュフローの推移。
Penumbra, Inc., together with its subsidiaries, designs, develops, manufactures, and markets medical devices in the United States and internationally. It offers computer-assisted vacuum thrombectomy; peripheral thrombectomy products, including the Indigo System for power aspiration of thrombus in the body; Lightning Flash, a mechanical thrombectomy system; Lightning Bolt 7, an arterial thrombectomy system; and CAT RX.
インタラクティブチャートと全財務諸表を見る → バリュエーションモデル（DCF）→
| 損益計算書 | TTM → 2026-06-30 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 | 2012-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 売上高合計 | $1.5B | $1.4B | $1.2B | $1.1B | $847M | $748M | $560M | $547M | $445M | $334M | $263M | $186M | $126M | $89M | $73M |
| 売上総利益 | $1.0B | $942M | $755M | $683M | $535M | $475M | $338M | $372M | $293M | $217M | $171M | $124M | $83M | $58M | $49M |
| 売上総利益率 % | 67.8% | 67.1% | 63.2% | 64.5% | 63.2% | 63.6% | 60.3% | 68.0% | 65.8% | 65.1% | 64.9% | 66.7% | 66.0% | 65.1% | 66.9% |
| 営業利益（EBIT） | $187M | $189M | $9M | $74M | $6M | ($8M) | ($39M) | $48M | ($1M) | $1M | ($1M) | $4M | $3M | ($1M) | $3M |
| 営業利益率 % | 12.4% | 13.5% | 0.8% | 7.0% | 0.7% | -1.0% | -7.0% | 8.7% | -0.2% | 0.4% | -0.5% | 2.2% | 2.4% | -1.3% | 4.7% |
| 当期純利益 | $161M | $178M | $14M | $91M | ($2M) | $3M | ($19M) | $48M | $7M | $5M | $15M | $2M | $2M | $4M | $2M |
| 純利益率 % | 10.7% | 12.7% | 1.2% | 8.6% | -0.2% | 0.4% | -3.4% | 8.8% | 1.5% | 1.4% | 5.6% | 1.3% | 1.8% | 4.6% | 2.7% |
| EBITDA | — | $223M | $46M | $109M | $30M | $9M | ($26M) | $56M | $36M | $5M | $1M | $6M | $4M | $0M | $3M |
| 1株当たり利益（EPS） | $4.07 | $4.52 | $0.36 | $2.32 | $-0.05 | $0.07 | $-0.54 | $1.34 | $0.18 | $0.13 | $0.44 | $0.17 | $0.09 | $0.17 | $0.08 |
| 発行済株式数（百万株） | — | 39M | 39M | 39M | 38M | 38M | 36M | 36M | 36M | 35M | 33M | 14M | 25M | 25M | 25M |
出典: 企業の公開資料（SEC）。数値をご利用の前に SEC EDGAR でご確認ください。
貸借対照表、キャッシュフロー計算書、四半期データおよび全財務比率は PEN のインタラクティブ・ビューアーでご覧いただけます。 /companies/us/PEN
本サイトの情報は教育および情報提供のみを目的としており、投資助言ではありません。目標株価や投資判断は掲載していません。
About TickerBase · Data methodology & sources · Privacy · Terms